Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Insider-Alarm: Warum Insider Millionen von Aktien dieses Goldwerts kaufen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 869020 | ISIN: US5951121038 | Ticker-Symbol: MTE
Tradegate
26.09.24
21:59 Uhr
98,30 Euro
-0,01
-0,01 %
Branche
Halbleiter
Aktienmarkt
S&P 500
NASDAQ-100
1-Jahres-Chart
MICRON TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
MICRON TECHNOLOGY INC 5-Tage-Chart
RealtimeGeldBriefZeit
98,1198,5126.09.
98,0998,7426.09.
GlobeNewswire (Europe)
63 Leser
Artikel bewerten:
(0)

Micron Technology, Inc. Reports Results for the Fourth Quarter and Full Year of Fiscal 2024

BOISE, Idaho, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its fourth quarter and full year of fiscal 2024, which ended August 29, 2024.

Fiscal Q4 2024 highlights

  • Revenue of $7.75 billion versus $6.81 billion for the prior quarter and $4.01 billion for the same period last year
  • GAAP net income of $887 million, or $0.79 per diluted share
  • Non-GAAP net income of $1.34 billion, or $1.18 per diluted share
  • Operating cash flow of $3.41 billion versus $2.48 billion for the prior quarter and $249 million for the same period last year

Fiscal 2024 highlights

  • Revenue of $25.11 billion versus $15.54 billion for the prior year
  • GAAP net income of $778 million, or $0.70 per diluted share
  • Non-GAAP net income of $1.47 billion, or $1.30 per diluted share
  • Operating cash flow of $8.51 billion versus $1.56 billion for the prior year

"Micron delivered 93% year-over-year revenue growth in fiscal Q4, as robust AI demand drove a strong ramp of our data center DRAM products and our industry-leading high bandwidth memory. Our NAND revenue record was led by data center SSD sales, which exceeded $1 billion in quarterly revenue for the first time," said Micron Technology President and CEO Sanjay Mehrotra. "We are entering fiscal 2025 with the best competitive positioning in Micron's history. We forecast record revenue in fiscal Q1 and a substantial revenue record with significantly improved profitability in fiscal 2025."

Quarterly Financial Results
(in millions, except per share amounts)
GAAP(1) Non-GAAP(2)
FQ4-24FQ3-24FQ4-23 FQ4-24FQ3-24FQ4-23
Revenue$7,750 $6,811 $4,010 $7,750 $6,811 $4,010
Gross margin 2,737 1,832 (435) 2,826 1,917 (366)
percent of revenue 35.3% 26.9% (10.8%) 36.5% 28.1% (9.1%)
Operating expenses 1,215 1,113 1,037 1,081 976 842
Operating income (loss) 1,522 719 (1,472) 1,745 941 (1,208)
percent of revenue 19.6% 10.6% (36.7%) 22.5% 13.8% (30.1%)
Net income (loss) 887 332 (1,430) 1,342 702 (1,177)
Diluted earnings (loss) per share 0.79 0.30 (1.31) 1.18 0.62 (1.07)
Annual Financial Results
(in millions, except per share amounts)
GAAP(1) Non-GAAP(2)
FY-24FY-23 FY-24FY-23
Revenue$25,111 $15,540 $25,111 $15,540
Gross margin 5,613 (1,416) 5,943 (1,196)
percent of revenue 22.4% (9.1%) 23.7% (7.7%)
Operating expenses 4,309 4,329 4,008 3,623
Operating income (loss) 1,304 (5,745) 1,935 (4,819)
percent of revenue 5.2% (37.0%) 7.7% (31.0%)
Net income (loss) 778 (5,833) 1,472 (4,862)
Diluted earnings (loss) per share 0.70 (5.34) 1.30 (4.45)

Investments in capital expenditures, net(2) were $3.08 billion for the fourth quarter of 2024 and $8.12 billion for the full year of 2024, which resulted in adjusted free cash flows(2) of $323 million for the fourth quarter of 2024 and $386 million for the full year of 2024. Micron ended the year with cash, marketable investments, and restricted cash of $9.16 billion. On September 25, 2024, Micron's Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on October 23, 2024, to shareholders of record as of the close of business on October 7, 2024.

Business Outlook

The following table presents Micron's guidance for the first quarter of 2025:

FQ1-25GAAP(1) OutlookNon-GAAP(2) Outlook
Revenue$8.70 billion ± $200 million$8.70 billion ± $200 million
Gross margin38.5% ± 1.0%39.5% ± 1.0%
Operating expenses$1.211 billion ± $15 million$1.085 billion ± $15 million
Diluted earnings per share$1.54 ± $0.08$1.74 ± $0.08

Further information regarding Micron's business outlook is included in the prepared remarks and slides, which have been posted at investors.micron.com.

Investor Webcast

Micron will host a conference call on Wednesday, September 25, 2024 at 2:30 p.m. Mountain Time to discuss its fourth quarter financial results and provide forward-looking guidance for its first quarter. A live webcast of the call will be available online at investors.micron.com. A webcast replay will be available for one year after the call. For Investor Relations and other company updates, follow us on X @MicronTech.

About Micron Technology, Inc.

We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND, and NOR memory and storage products through our Micron® and Crucial® brands. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence (AI) and compute-intensive applications that unleash opportunities - from the data center to the intelligent edge and across the client and mobile user experience. To learn more about Micron Technology, Inc. (Nasdaq: MU), visit micron.com.

© 2024 Micron Technology, Inc. All rights reserved. Micron, the Micron logo, and all other Micron trademarks are the property of Micron Technology, Inc. All other trademarks are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements regarding our industry, our strategic position, and our financial and operating results, including our guidance for the first quarter and full year fiscal 2025. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially. Please refer to the documents we file with the Securities and Exchange Commission, including our most recent Form 10-K and Form 10-Q. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in these forward-looking statements. These certain factors can be found at investors.micron.com/risk-factor. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to update any of the forward-looking statements to conform these statements to actual results.

(1)GAAP represents U.S. Generally Accepted Accounting Principles.
(2)Non-GAAP represents GAAP excluding the impact of certain activities, which management excludes in analyzing our operating results and understanding trends in our earnings, adjusted free cash flow, and business outlook. Further information regarding Micron's use of non-GAAP measures and reconciliations between GAAP and non-GAAP measures are included within this press release.
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
4th Qtr.3rd Qtr.4th Qtr.Year Ended
August 29,
2024
May 30,
2024
August 31,
2023
August 29,
2024
August 31,
2023
Revenue$7,750 $6,811 $4,010 $25,111 $15,540
Cost of goods sold 5,013 4,979 4,445 19,498 16,956
Gross margin 2,737 1,832 (435) 5,613 (1,416)
Research and development 903 850 719 3,430 3,114
Selling, general, and administrative 295 291 219 1,129 920
Restructure and asset impairments 1 - 4 1 171
Other operating (income) expense, net 16 (28) 95 (251) 124
Operating income (loss) 1,522 719 (1,472) 1,304 (5,745)
Interest income 131 136 134 529 468
Interest expense (136) (150) (129) (562) (388)
Other non-operating income (expense), net (7) 10 9 (31) 7
1,510 715 (1,458) 1,240 (5,658)
Income tax (provision) benefit (623) (377) 24 (451) (177)
Equity in net income (loss) of equity method investees - (6) 4 (11) 2
Net income (loss)$887 $332 $(1,430)$778 $(5,833)
Earnings (loss) per share
Basic$0.80 $0.30 $(1.31)$0.70 $(5.34)
Diluted 0.79 0.30 (1.31) 0.70 (5.34)
Number of shares used in per share calculations
Basic 1,108 1,107 1,095 1,105 1,093
Diluted 1,125 1,123 1,095 1,118 1,093
MICRON TECHNOLOGY, INC.
CONSOLIDATED BALANCE SHEETS
(In millions)
(Unaudited)
As ofAugust 29,
2024
May 30,
2024
August 31,
2023
Assets
Cash and equivalents$7,041 $7,594 $8,577
Short-term investments 1,065 785 1,017
Receivables 6,615 5,131 2,443
Inventories 8,875 8,512 8,387
Other current assets 776 1,297 820
Total current assets 24,372 23,319 21,244
Long-term marketable investments 1,046 775 844
Property, plant, and equipment 39,749 37,926 37,928
Operating lease right-of-use assets 645 660 666
Intangible assets 416 413 404
Deferred tax assets 520 597 756
Goodwill 1,150 1,150 1,150
Other noncurrent assets 1,518 1,415 1,262
Total assets$69,416 $66,255 $64,254
Liabilities and equity
Accounts payable and accrued expenses$7,299 $5,145 $3,958
Current debt 431 398 278
Other current liabilities 1,518 1,297 529
Total current liabilities 9,248 6,840 4,765
Long-term debt 12,966 12,860 13,052
Noncurrent operating lease liabilities 610 609 603
Noncurrent unearned government incentives 550 672 727
Other noncurrent liabilities 911 1,049 987
Total liabilities 24,285 22,030 20,134
Commitments and contingencies
Shareholders' equity
Common stock 125 125 124
Additional capital 12,115 11,794 11,036
Retained earnings 40,877 40,169 40,824
Treasury stock (7,852) (7,552) (7,552)
Accumulated other comprehensive income (loss) (134) (311) (312)
Total equity 45,131 44,225 44,120
Total liabilities and equity$69,416 $66,255 $64,254
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
For the year endedAugust 29,
2024
August 31,
2023
Cash flows from operating activities
Net income (loss)$778 $(5,833)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets 7,780 7,756
Stock-based compensation 833 596
Provision to write down inventories to net realizable value - 1,831
Goodwill impairment - 101
Change in operating assets and liabilities:
Receivables (3,581) 2,763
Inventories (488) (3,555)
Accounts payable and accrued expenses 1,915 (1,302)
Other current liabilities 989 (817)
Other 281 19
Net cash provided by operating activities 8,507 1,559
Cash flows from investing activities
Expenditures for property, plant, and equipment (8,386) (7,676)
Purchases of available-for-sale securities (1,999) (723)
Proceeds from maturities and sales of available-for-sale securities 1,794 1,591
Proceeds from government incentives 315 710
Other (33) (93)
Net cash provided by (used for) investing activities (8,309) (6,191)
Cash flows from financing activities
Repayments of debt (1,897) (761)
Payments of dividends to shareholders (513) (504)
Repurchases of common stock - repurchase program (300) (425)
Payments on equipment purchase contracts (149) (138)
Proceeds from issuance of debt 999 6,716
Other 18 95
Net cash provided by (used for) financing activities (1,842) 4,983
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash 40 (34)
Net increase (decrease) in cash, cash equivalents, and restricted cash (1,604) 317
Cash, cash equivalents, and restricted cash at beginning of period 8,656 8,339
Cash, cash equivalents, and restricted cash at end of period$7,052 $8,656
MICRON TECHNOLOGY, INC.
NOTES
(Unaudited)
Inventories

In 2023, we recorded charges of $1.83 billion to cost of goods sold to write down the carrying value of work in process and finished goods inventories to their estimated net realizable values ("NRV"). The impact of inventory NRV write-downs for each period reflects (1) inventory write-downs in that period, offset by (2) lower costs in that period on the sale of inventory written down in prior periods. The impacts of inventory NRV write-downs are summarized below:
4th Qtr.3rd Qtr.4th Qtr.Year Ended
August 29,
2024
May 30,
2024
August 31,
2023
August 29,
2024
August 31,
2023
Provision to write down inventory to NRV$-$-$-$-$(1,831)
Lower costs from sale of inventory written down in prior periods - - 563 987 844
$-$-$563$987$(987)
MICRON TECHNOLOGY, INC.
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In millions, except per share amounts)
4th Qtr.3rd Qtr.4th Qtr.Year Ended
August 29,
2024
May 30,
2024
August 31,
2023
August 29,
2024
August 31,
2023
GAAP gross margin$2,737 $1,832 $(435)$5,613 $(1,416)
Stock-based compensation 85 80 64 312 201
Other 4 5 5 18 19
Non-GAAP gross margin$2,826 $1,917 $(366)$5,943 $(1,196)
GAAP operating expenses$1,215 $1,113 $1,037 $4,309 $4,329
Stock-based compensation (128) (137) (87) (509) (363)
Restructure and asset impairments (1) - (4) (1) (171)
Patent cross-license agreement gain - - - 200 -
Goodwill impairment - - (101) - (101)
Litigation settlement - - - - (68)
Other (5) - (3) 9 (3)
Non-GAAP operating expenses$1,081 $976 $842 $4,008 $3,623
GAAP operating income (loss)$1,522 $719 $(1,472)$1,304 $(5,745)
Stock-based compensation 213 217 151 821 564
Restructure and asset impairments 1 - 4 1 171
Patent cross-license agreement gain - - - (200) -
Goodwill impairment - - 101 - 101
Litigation settlement - - - - 68
Other 9 5 8 9 22
Non-GAAP operating income (loss)$1,745 $941 $(1,208)$1,935 $(4,819)
GAAP net income (loss)$887 $332 $(1,430)$778 $(5,833)
Stock-based compensation 213 217 151 821 564
Restructure and asset impairments 1 - 4 1 171
Patent cross-license agreement gain - - - (200) -
Goodwill impairment - - 101 - 101
Litigation settlement - - - - 68
Other 5 3 7 - 32
Estimated tax effects of above and other tax adjustments 236 150 (10) 72 35
Non-GAAP net income (loss)$1,342 $702 $(1,177)$1,472 $(4,862)
GAAP weighted-average common shares outstanding - Diluted 1,125 1,123 1,095 1,118 1,093
Adjustment for stock-based compensation 12 13 - 16 -
Non-GAAP weighted-average common shares outstanding - Diluted 1,137 1,136 1,095 1,134 1,093
GAAP diluted earnings (loss) per share$0.79 $0.30 $(1.31)$0.70 $(5.34)
Effects of the above adjustments 0.39 0.32 0.24 0.60 0.89
Non-GAAP diluted earnings (loss) per share$1.18 $0.62 $(1.07)$1.30 $(4.45)
RECONCILIATION OF GAAP TO NON-GAAP MEASURES, Continued
4th Qtr.3rd Qtr.4th Qtr.Year Ended
August 29,
2024
May 30,
2024
August 31,
2023
August 29,
2024
August 31,
2023
GAAP net cash provided by operating activities$3,405 $2,482 $249 $8,507 $1,559
Expenditures for property, plant, and equipment (3,120) (2,086) (1,461) (8,386) (7,676)
Payments on equipment purchase contracts (22) (45) (26) (149) (138)
Proceeds from sales of property, plant, and equipment 12 41 18 99 92
Proceeds from government incentives 48 33 462 315 710
Investments in capital expenditures, net (3,082) (2,057) (1,007) (8,121) (7,012)
Adjusted free cash flow$323 $425 $(758)$386 $(5,453)

The tables above reconcile GAAP to non-GAAP measures of gross margin, operating expenses, operating income (loss), net income (loss), diluted shares, diluted earnings (loss) per share, and adjusted free cash flow. The non-GAAP adjustments above may or may not be infrequent or nonrecurring in nature, but are a result of periodic or non-core operating activities. We believe this non-GAAP information is helpful in understanding trends and in analyzing our operating results and earnings. We are providing this information to investors to assist in performing analysis of our operating results. When evaluating performance and making decisions on how to allocate our resources, management uses this non-GAAP information and believes investors should have access to similar data when making their investment decisions. We believe these non-GAAP financial measures increase transparency by providing investors with useful supplemental information about the financial performance of our business, enabling enhanced comparison of our operating results between periods and with peer companies. The presentation of these adjusted amounts varies from amounts presented in accordance with U.S. GAAP and therefore may not be comparable to amounts reported by other companies. Our management excludes the following items in analyzing our operating results and understanding trends in our earnings:

  • Stock-based compensation;
  • Gains and losses from settlements;
  • Restructure and asset impairments;
  • Goodwill impairment; and
  • The estimated tax effects of above, non-cash changes in net deferred income taxes, assessments of tax exposures, certain tax matters related to prior fiscal periods, and significant changes in tax law. The divergence between our GAAP and non-GAAP income tax provision relates to the difference in our GAAP and non-GAAP estimated annual effective tax rates, which are computed separately.

Non-GAAP diluted shares are adjusted for the impact of additional shares resulting from the exclusion of stock-based compensation from non-GAAP income (loss).

MICRON TECHNOLOGY, INC.
RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK
FQ1-25 GAAP Outlook Adjustments Non-GAAP Outlook
Revenue$8.70 billion ± $200 million - $8.70 billion ± $200 million
Gross margin38.5% ± 1.0% 1.0%A 39.5% ± 1.0%
Operating expenses$1.211 billion ± $15 million $126 millionB $1.085 billion ± $15 million
Diluted earnings per share(1)$1.54 ± $0.08 $0.20A, B, C $1.74 ± $0.08
Non-GAAP Adjustments
(in millions)
AStock-based compensation - cost of goods sold $87
AOther - cost of goods sold 4
BStock-based compensation - research and development 76
BStock-based compensation - sales, general, and administrative 50
CTax effects of the above items and other tax adjustments 3
$220
(1) GAAP earnings per share based on approximately 1.12 billion diluted shares and non-GAAP earnings per share based on approximately 1.14 billion diluted shares.

The tables above reconcile our GAAP to non-GAAP guidance based on the current outlook. The guidance does not incorporate the impact of any potential business combinations, divestitures, additional restructuring activities, balance sheet valuation adjustments, strategic investments, financing transactions, and other significant transactions. The timing and impact of such items are dependent on future events that may be uncertain or outside of our control.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.